$25 Million Home Infusion And Closed-Door Specialty Pharmacy

This Closed–Door Specialty Infusion Pharmacy held ACHC and URAC accreditations, and focused on Immune Globulin Therapy (IVIG) across two locations in Texas and Arkansas.

In 2018, the CFO requested to be bought out of the partnership. The CEO, James S., chose Andre Ulloa to find an investment and possible strategic partner.

Client

$25 million in revenue, adj. EBITDA of $4 million
ACHC and URAC accredited Closed–Door Specialty Infusion Pharmacy
Servicing a total of 34 states with in-home infusion services

Objective

Identify a capital partner that would purchase a majority of the business while providing operational and strategic support for growth initiatives.
Maintain decision-making authority for CEO and other senior management with employment and operations agreement.
Help to prepare the company for a sale through accounting and legal support.

Result

Sold the majority of the company to a healthcare focused joint venture partner for a premium valuation.
Vertically integrated the pharmacy supply chain and nursing staff with a large regional Home Health agency patient base.
Seamless staff and management transition to new ownership with previous CEO maintaining operation authority, board position, and equity membership.
Solidified a Definitive Agreement and worked side–by–side with our client to negotiate employment, operations, deferred payment, and equity terms.

“Our overall experience with Andre can only be described as outstanding. Their experienced team provided market information that was critical for receiving a premium valuation and fair deal terms. He played countless important roles during this process including advisor, negotiator, and even trusted confidant. It is not possible to overstate the value he brought to our business.”

James S.
Owner and CEO

Questions about the sale process or current multiples within your unique healthcare segment?